Funds holding “REGENERON PHARMACEUTICALS INC”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
7 positions across 7 funds. Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors Healthcare | Regeneron Pharmaceuticals Inc | 75886F107 | EC | 0.93% | $6.4M | Jun 30, 2026 | full (145 positions) |
| BME BlackRock Health Sciences Trust Healthcare | Regeneron Pharmaceuticals Inc | 75886F107 | EC | 0.84% | $4.8M | Jun 30, 2026 | full (152 positions) |
| HQH abrdn Healthcare Investors Healthcare | Regeneron Pharmaceuticals Inc | 75886F107 | EC | 0.52% | $7.1M | Jun 30, 2026 | full (154 positions) |
| USA Liberty All Star Equity Fund U.S. Equity | Regeneron Pharmaceuticals Inc | 75886F107 | EC | 0.36% | $7.2M | Jun 30, 2026 | full (148 positions) |
| GRX Gabelli Healthcare & WellnessRx Trust Healthcare | REGENERON PHARMACEUTICALS INC | 75886F107 | EC | 0.30% | $695K | Jun 30, 2026 | full (195 positions) |
| GOF Guggenheim Strategic Opportunities Fund Multi-Asset | REGENERON PHARMACEUTICALS INC | 75886F107 | EC | 0.00% | $14.8K | May 29, 2026 | full (1,841 positions) |
| BRW Saba Capital Income & Opportunities Fund U.S. Equity | Regeneron Pharmaceuticals Inc | 75886F107 | EC | -0.01% | $-45.8K | Jul 31, 2026 | full (1,143 positions) |
Matching position names
Regeneron Pharmaceuticals Inc · 5REGENERON PHARMACEUTICALS INC · 2
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.